Inhibitor

(redirected from Neuraminidase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.
Related to Neuraminidase inhibitor: Oseltamivir, amantadine, Tamiflu, Zanamivir

inhibitor

[in′hib·əd·ər]
(aerospace engineering)
A substance bonded, taped, or dip-dried onto a solid propellant to restrict the burning surface and to give direction to the burning process.
(chemistry)
A substance which is capable of stopping or retarding a chemical reaction; to be technically useful, it must be effective in low concentration.

Inhibitor

 

a circuit having m + n inputs and a single output, at which a signal can appear only when there are no signals on the m inputs (inhibiting). The other n inputs (principal) form one of the two logic connections, “AND” or “OR.” Inhibitors are used extensively in computers. They are very often understood to be a circuit having a single principal input and a single inhibiting input. A signal appears at the output of such a circuit when a signal is present on the principal input but there is none on the inhibiting input. Such an inhibitor is called an anticoincidence gate; its conventional representation is given in Figure 1.

Figure 1. Block diagram of an anticoincidence gate (inhibitor) with m — 1 and n 1:(A) principal input, (Q) inhibiting input, (Ga) anticoincidence gate

inhibitor

A substance added to paint to retard drying, skinning, mildew growth, etc. Also see corrosion inhibitor, inhibiting pigment, drying inhibitor.
References in periodicals archive ?
Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus.
Importantly, it has no cross-resistance with the neuraminidase inhibitors or adamantanes.
Patients with flulike illness who present outside the context of an influenza outbreak and are considered to be at low risk for influenza-related complications should be tested to confirm the diagnosis before starting antiviral treatment with a neuraminidase inhibitor, according to another decisional analysis study.
Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
Indeed, the number of patients who needed to be treated (NNT) with a neuraminidase inhibitor to prevent one additional case of acute otitis media was 18.
Another promising drug is peramivir, a neuraminidase inhibitor that appears to be effective and well tolerated.
InavirA is a long-acting neuraminidase inhibitor developed by Daiichi Sankyo which is manufactured in Japan.
TABLE 45 NEURAMINIDASE INHIBITOR MARKET SHARES BY REGION, 2010 (%) 87
To the Editor: In the Netherlands, the outbreak of pandemic influenza A (H1N1) 2009 led to a 100-fold increase from 2008 in prescriptions for the antiviral neuraminidase inhibitor oseltamivir (1).
Neuropsychiatric events associated with zanamivir and the other available neuraminidase inhibitor, oseltamivir (Tamiflu), were discussed at a meeting of the FDA's Pediatric Advisory Committee, and the panel narrowly recommended revising the labeling for both drugs to include information about these events.
Biota was responsible for zanamivir, a neuraminidase inhibitor, subsequently launched by GSK as Relenza(TM) in 1999 for the treatment of influenza.
BioCryst currently has two late-stage development programs: peramivir, a viral neuraminidase inhibitor for the treatment of influenza, and ulodesine (BCX4208), a purine nucleoside phosphorylase (PNP) inhibitor for the treatment of gout.